Stifel analyst Stephen Willey lowered the price target on Insmed (NASDAQ: INSM) to $205.00 (from $212.00) while maintaining a Buy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE